<VariationArchive RecordType="classified" VariationID="30707" VariationName="NM_025132.4(WDR19):c.3068dup (p.Tyr1023Ter)" VariationType="Duplication" Accession="VCV000030707" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-04-12" MostRecentSubmission="2015-04-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39664" VariationID="30707">
      <GeneList>
        <Gene Symbol="WDR19" FullName="WD repeat domain 19" GeneID="57728" HGNC_ID="HGNC:18340" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4p14</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="39182529" stop="39285810" display_start="39182529" display_stop="39285810" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="39184023" stop="39287429" display_start="39184023" display_stop="39287429" Strand="+" />
          </Location>
          <OMIM>608151</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025132.4(WDR19):c.3068dup (p.Tyr1023Ter)</Name>
      <CanonicalSPDI>NC_000004.12:39255913:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4p14</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="39255913" stop="39255914" display_start="39255913" display_stop="39255914" variantLength="1" positionVCF="39255913" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="39257533" stop="39257534" display_start="39257533" display_stop="39257534" variantLength="1" positionVCF="39257533" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y1023*</ProteinChange>
      <ProteinChange>Y863*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.39257534dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.39257534dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.39255914dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.39255914dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031813.1" sequenceAccession="NG_031813" sequenceVersion="1" change="g.78511dup">
            <Expression>NG_031813.1:g.78511dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317924.2" sequenceAccession="NM_001317924" sequenceVersion="2" change="c.2588dup">
            <Expression>NM_001317924.2:c.2588dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001304853.1" sequenceAccession="NP_001304853" sequenceVersion="1" change="p.Tyr863Ter">
            <Expression>NP_001304853.1:p.Tyr863Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025132.4" sequenceAccession="NM_025132" sequenceVersion="4" change="c.3068dup" MANESelect="true">
            <Expression>NM_025132.4:c.3068dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079408.3" sequenceAccession="NP_079408" sequenceVersion="3" change="p.Tyr1023Ter">
            <Expression>NP_079408.3:p.Tyr1023Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213038" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608151.0005" DB="OMIM" />
        <XRef Type="rs" ID="786205114" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025132.4(WDR19):c.3068dup (p.Tyr1023Ter) AND Nephronophthisis 13" Accession="RCV000023685" Version="3">
        <ClassifiedConditionList TraitSetID="7649">
          <ClassifiedCondition DB="MedGen" ID="C3280612">Nephronophthisis 13</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-11-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-04-12" MostRecentSubmission="2015-04-12">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22019273</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7649" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16690" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 13</ElementValue>
                <XRef ID="Nephronophthisis+13/8981" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013718" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP13</ElementValue>
                <XRef Type="MIM" ID="614377" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C3280612" DB="MedGen" />
              <XRef ID="MONDO:0013718" DB="MONDO" />
              <XRef Type="MIM" ID="614377" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50232" SubmissionDate="2015-04-10" DateLastUpdated="2015-04-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608151.0005_NEPHRONOPHTHISIS 13" title="WDR19, 1-BP DUP, 3068A_NEPHRONOPHTHISIS 13" />
        <ClinVarAccession Accession="SCV000044976" DateUpdated="2015-04-12" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-11-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp duplication in the WDR19 gene (3068dupA) that was found in compound heterozygous state in patients with nephronophthisis-13 (NPHP13; 614377) by Bredrup et al. (2011), see 608151.0004.</Attribute>
              <Citation>
                <ID Source="PubMed">22019273</ID>
              </Citation>
              <XRef DB="OMIM" ID="614377" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WDR19" />
          </GeneList>
          <Name>WDR19, 1-BP DUP, 3068A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 3068A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608151.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEPHRONOPHTHISIS 13</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50232" TraitType="Disease" MappingType="Name" MappingValue="NEPHRONOPHTHISIS 13" MappingRef="Preferred">
        <MedGen CUI="C3280612" Name="Nephronophthisis 13" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

